Diabetic Macular Edema (DME) Completed Phase 2 Trials for Dexamethasone (DB01234)

Also known as: Diabetic Macular Edema / Macular Edema, Diabetic / Diabetic Macular Oedema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01787669Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular OedemaTreatment
NCT01945866Phase II Combination Steroid and Anti-VEGF for Persistent DMETreatment
NCT01284478Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract SurgeryTreatment
NCT00464685Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular EdemaTreatment
NCT01951066Diabetic Macular Edema Treated With Ozurdex (DMEO)
NCT00799227Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular EdemaTreatment